Diabetes Management Guidelines

American Diabetes Association (ADA) 2013 Guidelines 

 

Updated recommendations are available. Click here. 

Source: American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(suppl 1):S11-S66.  

Jump to a section or click the arrow at the bottom right of each section 

Criteria for Diagnosis
A1C Testing
Individualized Treatment Goals
Type 2 Diabetes Risk Factors
Lifestyle Changes
Type 2 Diabetes Treatment
Insulin Therapy
Diabetes Self-Management
Obesity Treatment
Diabetes and Hypertension
Diabetes and Lipids
Diabetes and Cardiovascular Disease 
Microvascular Complications of Diabetes
Hypoglycemia
Foot Care
Diabetes in the Hospital
Diabetes and Quality of Life
Diabetes and Vaccines
Diabetes and Children
Diabetes and Pregnancy
Diabetes and Older Adults
Diabetes and Cystic Fibrosis
Type 1 Diabetes Screening and Insulin Therapy 

 Diabetes and Hypertension :: Goals and Treatment      Updated recommendations are available. Click here. 

Recommendations Slides

BP screening 

  • Measure BP at all routine visits; confirm elevated BP at separate visit 

BP goals 

  • <140 mm Hg systolic for persons with diabetes and hypertension  
    • Lower targets (such as <130 mm Hg) may be appropriate in certain patients if target can be achieved without treatment burden 
  • <80 mm Hg diastolic for patients with diabetes 

BP treatment  

  • BP ≥120/80 mm Hg  
    • Lifestyle changes: weight loss (if overweight), DASH-style diet including sodium restrictions, moderation of alcohol intake, increased physical activity 
  • BP ≥140/80 mm Hg 
    • Lifestyle changes  
    • Pharmacologic therapy  
      • ACEI or ARB for persons with diabetes and hypertension 
      • ≥2 agents at maximal doses usually required to achieve BP targets 
      • Administer ≥1 agent at bedtime 
      • Monitor serum creatinine/eGFR and serum potassium if using ACEI, ARB, or diuretic 
       
  • Pregnant women with diabetes and hypertension  
    • 110–129/65–79 mm Hg target goal 
    • ACEI, ARBs contraindicated 
 

ADA Guidelines: Hypertension and Blood Pressure Control (1 of 2) 

ADA Guidelines: Hypertension and Blood Pressure Control (2 of 2) 

Also see:  

ADA Guidelines: Glycemic, Blood Pressure, and Lipid Control  

 

 

Back Obesity Treatment  Next Diabetes and Lipids 

ACEI=angiotensin-converting enzyme inhibitor; ARB=angiotensin receptor blocker; BP=blood pressure; DASH=Dietary Approaches to Stop Hypertension; eGFR=estimated glomerular filtration rate 

The pharmacologic agents discussed are approved for use in the United States by the U.S. Food and Drug Administration (FDA) unless otherwise noted. Consult individual package inserts for use outside of the United States. 

January 2013 

This content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest.  

Back to
Clinical Guidelines 

BG Footer

Last Modified: 3/13/2014

Notice About Sponsored Content Clicking the banners below will direct you to sponsored content. KnowledgePoint360 does not endorse and bears no responsibility for sponsored content hosted on NDEI.org. For more information, please read our Editorial Policy

Advertisement